MyFinsight
Home
Blog
About
Contact
Download
Download image
Financial Royalty Assets
$594,992K
(10.29%↑ Y/Y)
Royalty Income Other
$35,584K
(23.74%↑ Y/Y)
Total income and other
revenues
$630,576K
(10.97%↑ Y/Y)
Operating income
$563,038K
(5.40%↑ Y/Y)
Total operating
expense, net
$67,538K
(98.26%↑ Y/Y)
Provision for changes in
expected cash flows from...
-$197,485K
(-55.33%↓ Y/Y)
Provision for credit
gaines on unfunded...
-$3,700K
Consolidated net income
before tax
$468,256K
(8.03%↑ Y/Y)
Total other expense,
net
-$94,782K
(5.92%↑ Y/Y)
Equity in earnings of
equity method...
$21,758K
(237.70%↑ Y/Y)
General and
administrative expenses...
$159,490K
(44.07%↑ Y/Y)
Interest income
$6,229K
(-44.83%↓ Y/Y)
Financial royalty asset
impairment
$69,443K
Research and development
funding expense
$39,790K
(-21.21%↓ Y/Y)
Consolidated net income
$468,256K
(8.03%↑ Y/Y)
Interest expense
$93,722K
(43.61%↑ Y/Y)
Gaines on equity
securities
-$20,166K
(56.04%↑ Y/Y)
Losses on available for
sale debt securities
-$6,680K
(-103.60%↓ Y/Y)
Other non-operating
expenses, net
-$2,201K
(28.12%↑ Y/Y)
Net income
attributable to royalty...
$294,690K
(23.64%↑ Y/Y)
Net income
attributable to...
$173,566K
(-11.03%↓ Y/Y)
Back
Back
Income Statement
1-svg
Royalty Pharma plc (RPRX)
1-svg
source: myfinsight.com
Royalty Pharma plc (RPRX)